Spansa Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Patna, Bihar, India, established in 2012.
2012 Patna, Bihar, India Active
Last Updated:
Access Report
About Spansa Pharmaceuticals Private Limited

Spansa Pharmaceuticals Private Limited, a active private limited company, was established on 03 September 2012 in Patna, Bihar, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232BR2012PTC019175. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Ram Gopal Jayaswal (Director), Anuj Kedia (Director), Ayush Kumar Kediya (Director). Past directors included Ram Gopal Jayaswal, Anuj Kedia, Niraj Kumar. It holds ₹2.33 Cr open charges and no settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor And First Floor, Nc-4B, Nandan Bhawan Gayatri Mandir Road, Kankarbagh, Patna, Bihar, 800020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232BR2012PTC019175

  • Registration Number

    019175

  • Incorporation Date

    03 September 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.33 Cr
  • Revenue Growth **** 25.47%
  • Profit Growth **** 23.50%
  • Ebitda **** 30.27%
  • Net Worth 34.97%
  • Total Assets **** 42.05%
Company report

Spansa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Spansa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Spansa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ram Gopal Jayaswal Director 27 Jul 2021 Current
Anuj Kedia Director 29 Oct 2018 Current
Ayush Kumar Kediya Director 03 Sep 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Oct 2021 Past
Pramod Abcsdd Additional Director 28 Sep 2019 Past
Pramod Abcsdd Director 01 Sep 2015 Past
Pramod Abcsdd Director 10 Jun 2013 Past
Pramod Abcsdd Director 02 Jan 2017 Past
Pramod Abcsdd Additional Director 26 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Spansa Pharmaceuticals.

Spansa Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.47% increase. The company also saw a substantial improvement in profitability, with a 23.5% increase in profit. The company's net worth Soared by an impressive increase of 34.97%.

Spansa Pharmaceuticals revenue growth over time
Spansa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.47%
*******
*******
*******
*******
Revenue from Operations
*******
 25.46%
*******
*******
*******
*******
Total Assets
*******
 42.05%
*******
*******
*******
*******
Profit or Loss
*******
 23.50%
*******
*******
*******
*******
Net Worth
*******
 34.97%
*******
*******
*******
*******
EBITDA
*******
 30.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Spansa Pharmaceuticals?

In 2021, Spansa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹23,342,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.33 Cr
Latest Charge Details
Date Lender Amount Status
25 Nov 2024 Hdfc Bank Limited ₹3.60 M Open
21 Aug 2023 Hdfc Bank Limited ₹1.70 M Open
23 Jul 2021 Hdfc Bank Limited ₹3.04 M Open
31 Jan 2019 Hdfc Bank Limited ₹1.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Spansa Pharmaceuticals?

Spansa Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Spansa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Spansa Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Spansa Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Spansa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 3.60 M with Charge ID 101042782 was registered on 25 Nov 2024. was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 15.00 M registered on 31 Jan 2019 with Charge ID 100242988 was modified on 25 Apr 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.70 M with Charge ID 100812247 was registered on 21 Aug 2023. was documented.

  • Director Appointment

    Progress on Ram Gopal Jayaswal was appointed as a Director was appointed as a Director on 27 Jul 2021 & has been associated with this company since 4 years 6 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Spansa Pharmaceuticals Private Limited?

The CIN of Spansa Pharmaceuticals Private Limited is U24232BR2012PTC019175.

Where is Spansa Pharmaceuticals Private Limited headquartered?

Spansa Pharmaceuticals Private Limited is headquartered at Ground Floor And First Floor, Nc-4B, Nandan Bhawan Gayatri Mandir Road, Kankarbagh, Patna, Bihar, 800020.

When was Spansa Pharmaceuticals Private Limited incorporated?

Spansa Pharmaceuticals Private Limited was incorporated on 03 September 2012.

Who are the current directors of Spansa Pharmaceuticals Private Limited?

The current directors of Spansa Pharmaceuticals Private Limited are

What is the primary industry of Spansa Pharmaceuticals Private Limited?

The primary industry of Spansa Pharmaceuticals Private Limited is Trade.

Is Spansa Pharmaceuticals Private Limited a listed company?

Spansa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Spansa Pharmaceuticals Private Limited?

The authorized capital of Spansa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Spansa Pharmaceuticals Private Limited?

The compliance status of Spansa Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available